Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Philip Morris strikes GBP1 billion Vectura buy

Fri, 09th Jul 2021 07:46

(Alliance News) - Stocks in London are set to regain some poise Friday after a sharp sell-off in the previous session, driven by worries that the more infectious Delta variant will set back the global economic recovery.

Unlikely to soothe these fears was data early Friday showing the UK economy grew for a fourth straight month in May, but by less than expected despite pubs and restaurants in England being able to serve indoors again.

Sterling gave up some overnight gains following the figures, quoted at USD1.3766 early Friday, flat against USD1.3763 at the London equities close on Thursday.

UK gross domestic product grew 0.8% in May from April, missing forecasts for a stronger monthly gain of 1.7%, according to FXStreet, and below April's growth of 2.0%, which itself was revised down from 2.3%. The economy remains 3.1% below its pre-virus levels, the ONS said.

In early UK company news, Marlboro cigarette maker Philip Morris International has agreed to buy Vectura in a GBP1.0 billion deal.

Victrex said it sees some upside to its current financial year, though cautioned on headwinds for the year after.

IG says futures indicate the FTSE 100 index of large-caps to open up 28.44 points, or 0.4%, at 7,059.10 on Friday. The FTSE 100 closed down 120.36 points, or 1.7%, at 7,030.66 on Thursday.

"The slide in US 10-year yields this week appears to suggest that bond investors are becoming increasingly concerned about a sharp slowdown in global and US growth prospects, as well as diminishing inflation expectations," said Michael Hewson, chief market analyst at CMC Markets.

He pointed towards the Japanese government's decision to bar fans from the Olympic Games as the Delta variant drives Covid-19 outbreaks in parts of Asia-Pacific and Africa, and cases rise again in Europe and the US.

Prime Minister Yoshihide Suga announced that Tokyo will be under a state of emergency throughout the Games, until August 22.

In Australia the government said it would rush 300,000 vaccine doses to Sydney as the country's largest city – in its third week of lockdown – struggled to bring a Delta outbreak under control. South Korea, once considered a coronavirus response model along with Australia, reported nearly 1,300 new infections Thursday, the highest since the pandemic began.

On the inflation front, China reported a slowdown in consumer price growth in June due to falling pork prices. China's consumer price index, a key gauge of retail inflation, rose 1.1% on-year in June – lower than analysts expected, and down from the month before.

The producer price index, which measures the cost of goods at the factory gate, rose 8.8% on-year – again edging down from May, when prices surged 9.0%.

"In June, preliminary effects of policies to stabilise the supply and cost of commodities can be seen...and the rise in prices of industrial products has slowed," said Dong Lijuan, senior statistician at the National Bureau of Statistics.

In Asia on Friday, the Japanese Nikkei 225 index closed down 0.6%. In China, the Shanghai Composite was flat, while the Hang Seng index in Hong Kong was up 1.0%. The S&P/ASX 200 in Sydney ended down 0.9%.

In the US on Thursday, Wall Street ended in the red, with the Dow Jones Industrial Average down 0.8%, the S&P 500 down 0.9% and the Nasdaq Composite down 0.7%.

However, London is poised for a higher start on Friday.

"Today's Asia session has seen further weakness, although much of that was a continuation of the sell-off from Thursday, with today's European open set to see a modest rebound, as investors weigh up whether this is simply another opportunity to buy the dip," said CMC's Hewson.

In early UK company news, Philip Morris International said it has agreed a deal to buy London-listed asthma treatment firm Vectura Group as Philip Morris looks to expand its reach beyond tobacco and nicotine.

Philip Morris will pay 150 pence per share in cash for Vectura, a Wiltshire, England-based inhaled drug delivery devices maker. Adding a 19p interim dividend, the deal values the FTSE 250 constituent at GBP1.04 billion.

Shares in Vectura closed at 135.6p on Thursday, giving the company a market capitalisation of GBP805 million.

Following the PMI offer, Vectura's directors withdrew their recommendation for a GBP958 million takeover by funds managed by private equity firm Carlyle Group Inc. PMI's offer is a 10% premium to Carlyle's 136p per share bid.

"PMI is expanding into products beyond tobacco and nicotine, as part of a natural evolution into a broader healthcare and wellness company," the New York-based company said.

In February, Philip Morris announced plans to generate at least USD1 billion of annual revenue from its Beyond Nicotine range by 2025. Respiratory delivery drugs are seen as key to that.

London-based commercial property developer Land Securities said it made good progress with rent collection in the June quarter.

As at July 7, 81% of net rent due on June 24 had been paid. Of the GBP18 million of rent outstanding, GBP6 million relates to customers who have withheld payment pending documentation of agreed concessions.

Landsec also confirmed that the first quarter dividend for the current financial year will be 7.0p per share, paid in October.

Derwent - a property developer and landlord focused on central London - also released a positive rent collection update, saying it has received 89% of total rent due for the June quarter, with a further 5% expected later.

Polymer supplier Victrex said it sees upside risk to current full-year expectations, but warned of headwinds for the 2022 financial year.

The company said it is seeing continued momentum in most end markets and posted 37% growth in third quarter revenue to GBP80.7 million, with sales volumes of 1,202 tonnes up 49% year-on-year.

On a year-to-date basis, being the nine months to June 30, revenue was up 10% year-on-year at GBP231.6 million.

"Reflecting the volume strength on a year to date basis, we now see the potential for some upside to current full year expectations, with our internal assumptions being closer to the upper end of market expectations," said Chief Executive Jakob Sigurdsson.

However, he noted that for the 2022 financial year, Victrex will have to contend with foreign currency headwinds, increasing raw material inflation, an anticipated uplift in innovation spend to support the long-term growth pipeline, and some costs associated with commissioning its China manufacturing facility.

"These effects will weigh on our 2022 prospects, although we remain focused on growth," said Sigurdsson.

The euro traded at USD1.1834 early Friday, down from USD1.1842 late Thursday. Against the yen, the dollar rose to JPY110.02 versus JPY109.79.

Gold was quoted at USD1,802.49 an ounce early Friday, higher than USD1,796.50 on Thursday. Brent oil was trading at USD74.34 a barrel, up from USD73.70 late Thursday.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
26 Nov 2018 09:05

Vectura Discontinues VR375 As Phase Three Study Misses Endpoints

LONDON (Alliance News) - Respiratory disease-focused pharmaceutical firm Vectura Group PLC said on Monday its phase three study of VR375 in adult and adolescent patients with severe uncontrolled a

Read more
22 Oct 2018 08:59

Vectura Says New Chief Financial Officer Fry Has Started Week Early

LONDON (Alliance News) - Medical devices developer Vectura Group PLC said Monday Paul Fry will become chief financial officer immediately, rather than from Monday next week.Fry succeeds who

Read more
11 Sep 2018 09:40

Vectura Interim Loss Narrows On Higher Revenue And Lower Expenses

LONDON (Alliance News) - Pharmaceutical firm Vectura Group PLC on Tuesday said its loss narrowed in the first half of 2018 as it reduced operating costs.Pretax loss narrowed to GBP29.9 in a

Read more
11 Sep 2018 08:18

Vectura's solid interims turn focus further forward

(Sharecast News) - Vectura kept guidance for the full year unchanged as the inhaled medicines specialist reported robust revenue and said it has identified pipeline projects with potential annual sales of over $250m.

Read more
10 Sep 2018 12:49

Vectura Launches Flutiform Inhaler In The UK, Europe To Follow

LONDON (Alliance News) - Vectura Group PLC said Monday that it launched its flutiform k-haler, an inhaler to treat asthma, in the UK.The company said it expects further launches across to a

Read more
4 Sep 2018 15:54

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 5 September Barratt DevelopmentsFull Year ResultsBreedon GroupHalf Year Year 6

Read more
23 Aug 2018 14:17

Thursday broker round-up

(Sharecast News) - TalkTalk: Barclays upgrades to overweight with a target price of 150p.

Read more
21 Aug 2018 12:31

Vectura concludes two paediatric studies into VR647

(Sharecast News) - Vectura announced the successful conclusion of two paediatric studies to support the potential use of VR647, its wholly-owned drug/device combination asset, on Tuesday.

Read more
21 Aug 2018 09:45

Vectura Group Gets Positive Results From VR647 Phase II Study

LONDON (Alliance News) - Vectura Group PLC said Tuesday that it received positive results form two paediatric studies of its VR647 inhalation system to manage asthma.The two studies, a and

Read more
17 May 2018 10:55

Vectura Group On Track To Achieve Expected Full-Year Revenue

LONDON (Alliance News) - Inhaled product design and development firm Vectura Group PLC said on Thursday based on its trading performance for the year-to-date revenue is currently in line with is a

Read more
11 May 2018 11:35

Nuformix Appoints Former Ventura Chief Executive To Board

LONDON (Alliance News) - Pharmaceutical company Nuformix PLC said Friday that it has appointed Christopher Blackwell, the former chief executive officer of Vectura Group PLC, as non-executive of a

Read more
10 May 2018 16:16

UK Shareholder Meetings Calendar - Next 7 Days

Friday 11 MayBBA AviationMan GroupRSA Insurance GroupJohn Wood Advanced 14 15 Pacific

Read more
24 Apr 2018 13:16

Sosei Group Confirms It Will Not Make Takeover Offer For Vectura

LONDON (Alliance News) - Japanese biotechnology firm Sosei Group Corp said on Tuesday, noting unspecified press reports, it does not intend to make an offer for Vectura Group PLC.Shares in

Read more
23 Apr 2018 09:55

Vectura Adds Ex-GSK And Sanofi Executive Whitaker To Board From June

LONDON (Alliance News) - Vectura PLC said Monday it has appointed Anne Whitaker as non-executive director of the drug development firm from the start of June.Whitaker served as president of

Read more
20 Apr 2018 09:59

Vectura CFO Andrew Derodra Leaves To Take Up Role At Unilabs

LONDON (Alliance News) - Vectura Group PLC on Friday said that its Chief Financial Officer Andrew Derodra will leave the FTSE 250-listed respiratory medicines maker to take a new role within the a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.